![Joan Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Joan Smith is the founder of Meliora Therapeutics, Inc., where the company was founded in 2021 and the title held is Head-Technical.
Mr. Smith is currently working at Surface Venture Management LLC as an Advisor since 2020.
Education includes an undergraduate degree from the Massachusetts Institute of Technology, conferred in 2013.
Aktive Positionen von Joan Smith
| Unternehmen | Position | Beginn |
|---|---|---|
Surface Ventures
 Surface Ventures Investment ManagersFinance Surface Ventures invests in companies located in the United States and Canada. The firm targets companies operating across a broad range of sectors and industries. It provides financing for pre-seed and seed stage capital requirements with an investment size ranging from USD 0.5 - 3 million. The firm acts as a lead investor and makes follow-on investments. | Berater | 01.09.2020 |
Meliora Therapeutics, Inc.
 Meliora Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops cancer therapies using science and machine learning | Gründer | 01.09.2021 |
Ausbildung von Joan Smith
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
97
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Surface Ventures
Surface Ventures Investment ManagersFinance Surface Ventures invests in companies located in the United States and Canada. The firm targets companies operating across a broad range of sectors and industries. It provides financing for pre-seed and seed stage capital requirements with an investment size ranging from USD 0.5 - 3 million. The firm acts as a lead investor and makes follow-on investments. | Finance |
Meliora Therapeutics, Inc.
Meliora Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops cancer therapies using science and machine learning | Commercial Services |
